TCL1 mice are the most commonly used preclinical model for chronic lymphocytic leukemia (CLL), a B-cell malignancy characterized by clonal CD5+ B-lymphocyte accumulation. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.